CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS.

Brain, Behavior, and Immunity
Bonnie N Dittel

Abstract

The regulation of the inflammatory response is often viewed as very complex with many cellular players. The type of immune response generated is dependent upon the nature of the immune stimulation. In autoimmunity, one of the most important players is the CD4 T cell. The CD4 T cell lineage consists of a number of phenotypically and functionally distinct subsets. The unique functions of CD4 T cells are often mediated by soluble factors, which shape the nature of the immune response. In a T cell-mediated autoimmune response, such as in multiple sclerosis (MS), the CD4 T cell is thought to orchestrate and drive the immune response resulting in inflammation within the central nervous system (CNS). The extent of the inflammation must be tightly controlled or permanent tissue damage will occur. In MS, progressive debilitating disease is thought to be due to such damage. In addition to promoting inflammation, the CD4 T cell lineage also has the capacity to prevent and downmodulate inflammation. This is accomplished by specific CD4 T regulatory (Treg) cells and other regulatory feedback mechanisms. Thus although the complexity of the immune system is often viewed as too complicated for a nonimmunologist to fully understand, there are p...Continue Reading

References

Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·J D SedgwickV ter Meulen
Jan 1, 1995·Immunology Today·S Nagata, T Suda
Mar 19, 1996·Proceedings of the National Academy of Sciences of the United States of America·K GerritseE Claassen
May 20, 1998·The Journal of Comparative Neurology·T J AndersonI R Griffiths
May 23, 1998·Annual Review of Immunology·I S Grewal, R A Flavell
Apr 20, 1999·The Journal of Experimental Medicine·K A Sabelko-DownesJ H Russell
Jul 17, 1999·Journal of Neuroimmunology·A LigersO Olerup
Jan 22, 2000·The Journal of Clinical Investigation·G C SuvannavejhS D Miller
Feb 10, 2000·Springer Seminars in Immunopathology·C Infante-Duarte, T Kamradt
Sep 24, 2002·Brain : a Journal of Neurology·Tanja KuhlmannWolfgang Brück
Nov 6, 2002·The Journal of Biological Chemistry·Sudeepta AggarwalAustin L Gurney
Jan 4, 2003·Nature Reviews. Immunology·Siamon Gordon
Jan 11, 2003·Science·Shohei HoriShimon Sakaguchi
Feb 1, 2003·Journal of the Neurological Sciences·C BjartmarB D Trapp
Feb 5, 2003·Brain : a Journal of Neurology·I M Medana, M M Esiri
Mar 4, 2003·Nature Immunology·Jason D FontenotAlexander Y Rudensky
Sep 10, 2003·Journal of Leukocyte Biology·Thomas W KleinHerman Friedman
Jul 1, 2004·The Journal of Cell Biology·Julia M EdgarIan R Griffiths
Jul 21, 2004·Current Opinion in Cell Biology·Brian W Guzik, Lawrence S B Goldstein
Jan 22, 2005·Neurologic Clinics·Amit Bar-Or
Jan 25, 2005·Nature Medicine·Frank L HeppnerAdriano Aguzzi
Mar 18, 2005·Annual Review of Immunology·Tadamitsu Kishimoto
Mar 18, 2005·Annual Review of Immunology·Rebecca J GreenwaldArlene H Sharpe
Jun 14, 2005·Journal of the Neurological Sciences·Ralf A LinkerRalf Gold
Jun 17, 2005·Journal of Neuroscience Research·Eugene D PonomarevBonnie N Dittel
Sep 20, 2005·Critical Reviews in Immunology·Andrew J FleetwoodJohn A Hamilton
Oct 26, 2005·Journal of Autoimmunity·Robert S Wildin, Antonio Freitas
Jun 3, 2006·The Journal of Clinical Investigation·Séverine Le Bras, Raif S Geha
Jan 5, 2007·Annual Review of Immunology·Casey T WeaverLaurie E Harrington
Jan 30, 2007·Trends in Molecular Medicine·Makoto Miyara, Shimon Sakaguchi
Sep 22, 2007·The Journal of Biological Chemistry·Lai WeiJohn J O'Shea
Oct 5, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Eugene D PonomarevBonnie N Dittel

❮ Previous
Next ❯

Citations

Apr 29, 2009·Molecular and Cellular Biology·Lindzy F DodsonJonathan M Green
Feb 1, 2013·Infectious Diseases in Obstetrics and Gynecology·Janina JiangKathleen A Kelly
May 16, 2014·Endocrine-related Cancer·Frank Weber
Aug 2, 2014·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Megan Strachan-WhaleyV Wee Yong
Nov 7, 2014·Multiple Sclerosis International·Samuel S DuffyGila Moalem-Taylor
May 23, 2014·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Zhenyi XueRongxin Zhang
Jan 16, 2009·Trends in Immunology·Li TianCarl G Gahmberg
Dec 5, 2015·Frontiers in Cellular Neuroscience·Beatriz AlmoldaBernardo Castellano
Sep 29, 2009·Perspectives in Psychiatric Care·Jessica M GillGayle Page
Dec 11, 2014·Chemistry & Biodiversity·Eun Jung JangEun Sook Hwang
Feb 8, 2011·Journal of Neuroimmunology·Tanya LegerMarzia Malcangio
Jun 7, 2014·Frontiers in Cellular Neuroscience·Dora Brites, Ana R Vaz
Jul 13, 2012·Journal of Pharmacological Sciences·Irena LavrnjaMirjana Stojiljkovic
Jan 17, 2012·Journal of Agricultural and Food Chemistry·Junping XinSusan O McGuire
Jan 10, 2018·Frontiers in Immunology·Suzanne A B M AartsEsther Lutgens
Jul 23, 2014·Environmental Health Perspectives·Lisbeth A BouleB Paige Lawrence
Apr 27, 2018·Stroke; a Journal of Cerebral Circulation·Wei-Na JinQiang Liu
Sep 22, 2018·Chembiochem : a European Journal of Chemical Biology·Hye Jin LeeWeibo Cai
Jul 1, 2020·Molecular Biology Reports·Rasoul MirzaeiFaezeh Ghasemi
May 18, 2016·The Journal of Immunology : Official Journal of the American Association of Immunologists·Olga V BritanovaDmitriy M Chudakov
Jul 30, 2020·Current Diabetes Reports·Martin G Scherm, Carolin Daniel
Dec 18, 2020·Frontiers in Endocrinology·Martin G Scherm, Carolin Daniel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Related Papers

Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte
Burkhard BecherMelanie Greter
Allergology International : Official Journal of the Japanese Society of Allergology
Toshimasa Aranami, Takashi Yamamura
Clinical and Experimental Immunology
J M FletcherKingston H G Mills
© 2021 Meta ULC. All rights reserved